Cargando…

HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy

BACKGROUND: The clinical significance and cellular sources of residual human immunodeficiency virus type 1 (HIV-1) production despite suppressive combination antiretroviral therapy (cART) remain unclear and the effect of low-level viremia on T-cell homeostasis is still debated. METHODOLOGY/PRINCIPAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mavigner, Maud, Delobel, Pierre, Cazabat, Michelle, Dubois, Martine, L'Faqihi-Olive, Fatima-Ezzahra, Raymond, Stéphanie, Pasquier, Christophe, Marchou, Bruno, Massip, Patrice, Izopet, Jacques
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765414/ https://www.ncbi.nlm.nih.gov/pubmed/19876401 http://dx.doi.org/10.1371/journal.pone.0007658

Ejemplares similares

Genotypic prediction of HIV-1 subtype D tropism
por: Raymond, Stéphanie, et al.
Publicado: (2011)

Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure
por: Delobel, Pierre, et al.
Publicado: (2011)

Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens
por: Mansuy, Jean Michel, et al.
Publicado: (2017)

CD45RC Isoform Expression Identifies Functionally Distinct T Cell Subsets Differentially Distributed between Healthy Individuals and AAV Patients
por: Ordonez, Laurence, et al.
Publicado: (2009)

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism
por: Jeanne, Nicolas, et al.
Publicado: (2015)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy
por: Pasquier, Christophe, et al.
Publicado: (2017)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016)

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use
por: Raymond, Stéphanie, et al.
Publicado: (2017)

Quantification of HEV RNA by Droplet Digital PCR
por: Nicot, Florence, et al.
Publicado: (2016)

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
por: Mellberg, Tomas, et al.
Publicado: (2011)

Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection
por: Boyd, Anders, et al.
Publicado: (2014)

Interleukin-17-producing decidual CD4+ T cells are not deleterious for human pregnancy when they also produce interleukin-4
por: Lombardelli, Letizia, et al.
Publicado: (2016)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation
por: Masip, Jenifer, et al.
Publicado: (2022)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Low-level residual viremia and risk of virological failure
por: Cologni, G, et al.
Publicado: (2010)

Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy
por: Erdmann, Nathaniel B., et al.
Publicado: (2018)

Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
por: Archin, Nancie M., et al.
Publicado: (2010)

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy
por: Cillo, Anthony R., et al.
Publicado: (2014)

Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy
por: Younas, Mehwish, et al.
Publicado: (2021)

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
por: Cheng, Chien-Yu, et al.
Publicado: (2014)

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2011)

Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non‐responders
por: Yang, Xiaodong, et al.
Publicado: (2020)

Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy
por: Jacobs, Jana L., et al.
Publicado: (2020)

Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013)

Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil
por: Gomes, Samara Tatielle M., et al.
Publicado: (2017)

Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy
por: Botha-Le Roux, Shani, et al.
Publicado: (2022)

The PPARα pathway in Vγ9Vδ2 T cell anergy
por: Poupot, Mary, et al.
Publicado: (2014)

Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study
por: Bonnet, Eric, et al.
Publicado: (2013)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hvrp1m26cveoc2pavokuiekqte